Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pertuzumab/trastuzumab/docetaxel improves progression-free survival in HER2+ breast cancer

July 15, 2011

BioMarin's BMN-673 enters phase I trial in advanced hematological malignancies

July 15, 2011

FDA's ODAC recommends accelerated approval of Adcetris for Hodgkin's lymphoma and ACLC

July 15, 2011

OncoVista Innovative Therapies begins additional animal safety study of OVI-117

July 15, 2011

Phase II trial shows aviscumine may improve survival in metastatic melanoma

July 15, 2011

Aslan Pharmaceuticals licenses ARRY-543 from Array BioPharma

July 15, 2011

PU-H71 enters first-in-human phase I study in advanced malignancies

July 15, 2011

Everolimus improves response to trastuzumab in metastatic breast cancer

July 15, 2011

Celecoxib may prevent lung cancer development/progression in former smokers

July 15, 2011

BioAlliance gives update on Livatag and Clonidine Lauriad

July 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...